Department of Pathology, Tohoku University Graduate School of Medicine, Japan.
Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Japan; Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital, Japan; Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA.
J Steroid Biochem Mol Biol. 2020 Nov;204:105764. doi: 10.1016/j.jsbmb.2020.105764. Epub 2020 Sep 28.
Cortisol-producing adrenocortical adenomas (CPAs) are associated with ACTH-independent Cushing's syndrome and histologically composed of two cellular subtypes: compact (lipid-poor) and clear (lipid-rich) tumor cells. However, the details of hormonal and biological activities of these tumor cells have remained unknown, especially in CPAs. CPAs frequently harbored unique histological features different from those of aldosterone-producing adenomas (APAs) including a senescent phenotype. Therefore, we explored the association between morphological features and the immunoreactivity of steroidogenic enzymes in CPAs with different genotypes and compared them with cellular senescence markers as well as clinicopathological factors of the cases. Hormonal activities (3βHSD, CYP21A, CYP17A1, CYP11B1 and DHEA-ST) and cellular senescence markers (p16, p21 and Ki-67) within different morphological features (clear and compact) were evaluated in 40 CPAs. CPA genotypes (PRKACA, GNAS and CTNNB1) were examined by Sanger sequencing and then compared them with the factors above. p21 immunoreactivity was significantly positively correlated with that of CYP21A (p = 0.0110), CYP17A1 (p = 0.0356) and DHEA-ST (p = 0.0420) but inversely with tumor size (p = 0.0015). CYP21A (p = 0.0016), CYP11B1 (p = 0.0001), CYP17A1 (p < 0.0001) and p16 (p = 0.0137) immunoreactivity were all significantly higher in compact cells than those in clear cells. CYP17A1 (p = 0.0056) and 3βHSD (p = 0.0437) immunoreactivity was significantly higher in PRKACA-mutated than wild type CPAs. p16 immunoreactivity and serum DHEA-S level were both significantly higher in GNAS-mutated than PRKACA-mutated (p = 0.0250) and wild type (p = 0.0180) CPAs. Results of our present study did demonstrate that compact tumor cells were hormonally active and more senescent than clear tumor cells in CPAs. PRKACA- and GNAS-mutated tumor cells were more hormonally active and senescent than those without mutations despite the similar morphological features. We herein proposed a novel histological classification of the tumor cell subtypes based on in situ cortisol excess, genotypes and the status of cell senescence in CPAs.
促肾上腺皮质激素(ACTH)非依赖性库欣综合征相关的皮质醇分泌腺瘤(CPAs)组织学上由两种细胞亚型组成:致密(脂质贫乏)和透明(脂质丰富)肿瘤细胞。然而,这些肿瘤细胞的激素和生物学活性的细节仍然未知,尤其是在 CPAs 中。CPAs 经常具有不同于醛固酮分泌腺瘤(APAs)的独特组织学特征,包括衰老表型。因此,我们探索了不同基因型 CPAs 中形态特征与类固醇生成酶免疫反应之间的关系,并将其与细胞衰老标志物以及病例的临床病理因素进行了比较。在 40 例 CPAs 中评估了不同形态特征(透明和致密)内的激素活性(3βHSD、CYP21A、CYP17A1、CYP11B1 和 DHEA-ST)和细胞衰老标志物(p16、p21 和 Ki-67)。通过 Sanger 测序检查 CPAs 的基因型(PRKACA、GNAS 和 CTNNB1),然后将其与上述因素进行比较。p21 免疫反应性与 CYP21A(p=0.0110)、CYP17A1(p=0.0356)和 DHEA-ST(p=0.0420)显著正相关,但与肿瘤大小呈负相关(p=0.0015)。CYP21A(p=0.0016)、CYP11B1(p=0.0001)、CYP17A1(p<0.0001)和 p16(p=0.0137)免疫反应性在致密细胞中均显著高于透明细胞。CYP17A1(p=0.0056)和 3βHSD(p=0.0437)免疫反应性在 PRKACA 突变型 CPAs 中明显高于野生型。p16 免疫反应性和血清 DHEA-S 水平在 GNAS 突变型 CPAs 中均明显高于 PRKACA 突变型(p=0.0250)和野生型(p=0.0180)CPAs。我们目前的研究结果确实表明,CPAs 中的致密肿瘤细胞比透明肿瘤细胞更具有激素活性和衰老。尽管形态特征相似,但 PRKACA 和 GNAS 突变型肿瘤细胞比无突变型肿瘤细胞更具有激素活性和衰老。我们在此提出了一种基于 CPAs 中皮质醇过量、基因型和细胞衰老状态的肿瘤细胞亚型的新组织学分类。